Leadership Overview
Genesis Biotechnology Group has 4 executives leading key functions including information technology, operations, human resources, and strategy.
Driven by scientific advancement, Genesis Biotechnology Group is dedicated to providing essential basic science products for diagnostic essays and drug discovery, impacting the research landscape from its New Jersey headquarters.
Driven by scientific advancement, Genesis Biotechnology Group is dedicated to providing essential basic science products for diagnostic essays and drug discovery, impacting the research landscape from its New Jersey headquarters.
Leadership Roles at Genesis Biotechnology Group
Martin Adelson - Chief Operating Officer
Martin Adelson, the Chief Operating Officer at Genesis Biotechnology Group, manages the day-to-day operational execution of the company's research and development activities. Adelson directs the efficient delivery of basic science products, including diagnostic essays and drug discovery services, ensuring adherence to quality standards and timelines. This executive oversees the integration of scientific processes with business objectives, driving operational excellence across all functional areas. By optimizing resource allocation and streamlining workflows, Martin Adelson enhances the company's capacity to support complex research projects. The Chief Operating Officer's responsibilities include fostering a culture of continuous improvement within the operational teams and ensuring that all research activities align with Genesis Biotechnology Group's strategic goals. Adelson's leadership ensures the reliable and effective provision of scientific products to clients.
Raymond Poon - President
Raymond Poon, the President at Genesis Biotechnology Group, provides overarching strategic direction and executive leadership for the organization. Poon guides the company's vision and long-term growth initiatives, focusing on the advancement of basic science products for diagnostic essays and drug discovery. This leadership position involves fostering key relationships with stakeholders, partners, and the scientific community to expand market reach and impact. By setting the strategic course, Raymond Poon ensures that all operational and research efforts are aligned with Genesis Biotechnology Group's core objectives. The President's responsibilities encompass driving innovation, overseeing financial performance, and championing the company's commitment to scientific excellence. Poon's leadership is pivotal in navigating the complexities of the R&D landscape and solidifying the company's position in the market.
Boris Bogomolnik - Chief Information Officer
Boris Bogomolnik, the Chief Information Officer at Genesis Biotechnology Group, directs the company's technology infrastructure and digital strategy. Bogomolnik oversees the implementation and maintenance of all IT systems, ensuring robust data security and efficient information flow critical for research operations. This leadership role involves architecting scalable technology solutions that support the development of diagnostic essays and drug discovery initiatives. By optimizing data management and access, Boris Bogomolnik enhances the productivity of research teams and facilitates seamless collaboration across departments. The Chief Information Officer's purview extends to evaluating emerging technologies that can accelerate scientific breakthroughs and maintain Genesis Biotechnology Group's competitive edge in the R&D sector. Bogomolnik ensures technology investments directly align with the company's core mission of advancing basic science products.
Stephanie Berry - Chief Human Resources Officer
Stephanie Berry, the Chief Human Resources Officer at Genesis Biotechnology Group, leads all aspects of talent management and organizational development. Berry oversees the recruitment, retention, and professional growth of the scientific and administrative staff essential for the company's research endeavors. This critical role involves developing and implementing HR strategies that support Genesis Biotechnology Group's mission in diagnostic essays and drug discovery. By cultivating a positive and productive work environment, Stephanie Berry ensures that the company attracts and retains top scientific talent. The Chief Human Resources Officer also manages employee relations, compensation, and benefits programs, aligning human capital with business objectives. Berry's strategic direction in human resources strengthens the organizational foundation, enabling sustained innovation and operational success in the R&D sector.
Explore Leadership Teams in Business Services
NeoGenomics, Inc together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients oncology programs, as well as acts as a reference laboratory supplying anatomic pathology testing services. NeoGenomics is headquartered in Fort Myers, Florida.
Company Leadership DO

MB
DL
Tigermed provides contract research organization services in China and internationally. It operates through Clinical Trial Solutions; and Clinical-Related and Laboratory Services. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting; clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system; and biometrics services covering data management, biostatistics, and statistical programming. Tigermed was founded in 2004 and is located in Beijing, China.
Company Leadership
BS
JM
HW
Founded in 1999 and headquartered in Danvers, Massachusetts, Cell Signaling Technology is a life sciences company providing researchers with products and services that support scientific discovery. The company's products include; antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents used to study the cell signaling pathways that impact human health.
Company Leadership MC
CT
RP
Indigo, headquartered in Boston, Massachusetts, is a company that improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies.
Company Leadership
DB
RN
SV